JS Lee

VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 – PEARLS/KEYNOTE-091 study

L. Paz-Ares, E O’Brien, M. Mauer et al. · Annals of Oncology · 2022 · 72 citations · Full text

Medicine, Oncology, Pharmacology +16

Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor

Y Suh, K-C Yoo, Nizam Uddin et al. · Oncogene · 2015 · 58 citations

Medicine, Cell Biology, Oncology +12

Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment

Gabrielle S. Wong, JS Lee, Y-Y Park et al. · Oncogenesis · 2013 · 49 citations · Full text

Medicine, Molecular Biology, Oncology +17

Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay [published erratum appears in Blood 1995 Dec 15;86(12):4710]

Y-K. Kang, Zhiqing Zhan, Joanna Regis et al. · Blood · 1995 · 42 citations · Full text

Medicine, Hematology, Oncology +12

Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease

Jung Kh, Kim Jj, JS Lee et al. · Scandinavian Journal of Rheumatology · 2013 · 40 citations

Veterinary Medicine, Immunology, Internal Medicine +11